Unlike the tumorigenesis effect of ERα, ERβ has been suggested to act as a tumor suppressor in breast tissue because its expression declines during carcinogenesis, its knockdown increases the proliferation of mammary epithelial and BC cells. The gene discussed is ESR2; the disease is neoplasm.